The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
MMR Vaccines-Global Market Insights and Sales Trends 2024
Synopsis
The MMR vaccine (also known as the MPR vaccine after the Latin names of the diseases) is an immunization vaccine against measles, mumps, and rubella (German measles). It is a mixture of live attenuated viruses of the three diseases, administered via injection. It was first developed by Maurice Hilleman while at Merck.
The global MMR Vaccines market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of MMR Vaccines in various end use industries. The expanding demands from the Pediatrics, Adolescents, Adults and Elderly, are propelling MMR Vaccines market. Monovalent, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Combinational segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for MMR Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global MMR Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global MMR Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, MMR Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of MMR Vaccines covered in this report include GlaxoSmithKline, Medlmmune, Merck, Sanofi Pasteur and Serum Institute, etc.
The global MMR Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Medlmmune
Merck
Sanofi Pasteur
Serum Institute
Global MMR Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global MMR Vaccines market, Segment by Type:
Monovalent
Combinational
Divalent
Trivalent
Global MMR Vaccines market, by Application
Pediatrics
Adolescents
Adults
Elderly
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of MMR Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of MMR Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The MMR vaccine (also known as the MPR vaccine after the Latin names of the diseases) is an immunization vaccine against measles, mumps, and rubella (German measles). It is a mixture of live attenuated viruses of the three diseases, administered via injection. It was first developed by Maurice Hilleman while at Merck.
The global MMR Vaccines market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of MMR Vaccines in various end use industries. The expanding demands from the Pediatrics, Adolescents, Adults and Elderly, are propelling MMR Vaccines market. Monovalent, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Combinational segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for MMR Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global MMR Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global MMR Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, MMR Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of MMR Vaccines covered in this report include GlaxoSmithKline, Medlmmune, Merck, Sanofi Pasteur and Serum Institute, etc.
The global MMR Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Medlmmune
Merck
Sanofi Pasteur
Serum Institute
Global MMR Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global MMR Vaccines market, Segment by Type:
Monovalent
Combinational
Divalent
Trivalent
Global MMR Vaccines market, by Application
Pediatrics
Adolescents
Adults
Elderly
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of MMR Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of MMR Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 MMR Vaccines Market Overview
1.1 MMR Vaccines Product Overview
1.2 MMR Vaccines Market Segment by Type
1.2.1 Monovalent
1.2.2 Combinational
1.2.3 Divalent
1.2.4 Trivalent
1.3 Global MMR Vaccines Market Size by Type
1.3.1 Global MMR Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global MMR Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global MMR Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America MMR Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe MMR Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific MMR Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America MMR Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa MMR Vaccines Sales Breakdown by Type (2018-2023)
2 Global MMR Vaccines Market Competition by Company
2.1 Global Top Players by MMR Vaccines Sales (2018-2023)
2.2 Global Top Players by MMR Vaccines Revenue (2018-2023)
2.3 Global Top Players by MMR Vaccines Price (2018-2023)
2.4 Global Top Manufacturers MMR Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 MMR Vaccines Market Competitive Situation and Trends
2.5.1 MMR Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by MMR Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in MMR Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into MMR Vaccines Market
2.8 Key Manufacturers MMR Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 MMR Vaccines Status and Outlook by Region
3.1 Global MMR Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global MMR Vaccines Historic Market Size by Region
3.2.1 Global MMR Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global MMR Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global MMR Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global MMR Vaccines Forecasted Market Size by Region
3.3.1 Global MMR Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global MMR Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global MMR Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global MMR Vaccines by Application
4.1 MMR Vaccines Market Segment by Application
4.1.1 Pediatrics
4.1.2 Adolescents
4.1.3 Adults
4.1.4 Elderly
4.2 Global MMR Vaccines Market Size by Application
4.2.1 Global MMR Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global MMR Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global MMR Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America MMR Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe MMR Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific MMR Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America MMR Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa MMR Vaccines Sales Breakdown by Application (2018-2023)
5 North America MMR Vaccines by Country
5.1 North America MMR Vaccines Historic Market Size by Country
5.1.1 North America MMR Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America MMR Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America MMR Vaccines Sales in Value by Country (2018-2023)
5.2 North America MMR Vaccines Forecasted Market Size by Country
5.2.1 North America MMR Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America MMR Vaccines Sales in Value by Country (2024-2029)
6 Europe MMR Vaccines by Country
6.1 Europe MMR Vaccines Historic Market Size by Country
6.1.1 Europe MMR Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe MMR Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe MMR Vaccines Sales in Value by Country (2018-2023)
6.2 Europe MMR Vaccines Forecasted Market Size by Country
6.2.1 Europe MMR Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe MMR Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific MMR Vaccines by Region
7.1 Asia-Pacific MMR Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific MMR Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific MMR Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific MMR Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific MMR Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific MMR Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific MMR Vaccines Sales in Value by Region (2024-2029)
8 Latin America MMR Vaccines by Country
8.1 Latin America MMR Vaccines Historic Market Size by Country
8.1.1 Latin America MMR Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America MMR Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America MMR Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America MMR Vaccines Forecasted Market Size by Country
8.2.1 Latin America MMR Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America MMR Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa MMR Vaccines by Country
9.1 Middle East and Africa MMR Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa MMR Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa MMR Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa MMR Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa MMR Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa MMR Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa MMR Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline MMR Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline MMR Vaccines Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Medlmmune
10.2.1 Medlmmune Company Information
10.2.2 Medlmmune Introduction and Business Overview
10.2.3 Medlmmune MMR Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Medlmmune MMR Vaccines Products Offered
10.2.5 Medlmmune Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck MMR Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck MMR Vaccines Products Offered
10.3.5 Merck Recent Development
10.4 Sanofi Pasteur
10.4.1 Sanofi Pasteur Company Information
10.4.2 Sanofi Pasteur Introduction and Business Overview
10.4.3 Sanofi Pasteur MMR Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Pasteur MMR Vaccines Products Offered
10.4.5 Sanofi Pasteur Recent Development
10.5 Serum Institute
10.5.1 Serum Institute Company Information
10.5.2 Serum Institute Introduction and Business Overview
10.5.3 Serum Institute MMR Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Serum Institute MMR Vaccines Products Offered
10.5.5 Serum Institute Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 MMR Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 MMR Vaccines Industrial Chain Analysis
11.4 MMR Vaccines Market Dynamics
11.4.1 MMR Vaccines Industry Trends
11.4.2 MMR Vaccines Market Drivers
11.4.3 MMR Vaccines Market Challenges
11.4.4 MMR Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 MMR Vaccines Distributors
12.3 MMR Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
